Back to CITIGROUP INC CITIGROUP INC

CURXCURX
2 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in CURANEX PHARMACEUTICALS INC

Yes. Citigroup holds 8,957 shares of CURX (Curanex Pharmaceuticals), worth $2,375, as of its Q2 2026 13F filing. It reduced the position by 10,375 shares (-53.7%) from Q1 2026. Citigroup has held CURX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$2,375

Current Shares

8,957

Total Value Change

-$7,509

Total Shares Change

-10,375

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8,957
-53.7%
$2,3750.0%$0.27
0
2026-Q1
New
19,332
-
$9,8840.0%$0.46
26

Other major holders of CURX: GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, CITADEL ADVISORS LLC, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used